title: Trichomegaly following treatment with gefitinib (ZD1839).
authors.forename: J C
authors.initials: JC
authors.lastname: Pascual
authors.forename: J
authors.initials: J
authors.lastname: Bañuls
authors.forename: I
authors.initials: I
authors.lastname: Belinchon
authors.forename: M
authors.initials: M
authors.lastname: Blanes
authors.forename: B
authors.initials: B
authors.lastname: Massuti
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D004791:Enzyme Inhibitors / Q000009:adverse effects; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D005260:Female; D000077156:Gefitinib; D006201:Hair Diseases / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D011799:Quinazolines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D011799:Quinazolines; D066246:ErbB Receptors; D000077156:Gefitinib